Inmedix key facts
as of Oct 2026- Developer of a medical technology designed to assess autonomic nervous system function with clinical precision.
- Inmedix is valued at approximately $33.5M as of Oct 2026, set at its later-stage round, Nov 2024; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $16.3M across 3 recorded rounds; the latest was Seed Round ($720K) in Aug 2024.
- Notable investors include Keiretsu Forum, Cairi Legacy Partners, Andrew Holman, Keiretsu Capital, NW Angel — 8 tracked in total.
- Inmedix has filed 5 Form Ds with the SEC since 2021, most recently Oct 2025 ($160K sold to 4 investors).
- Status: Privately Held (backing).
Valued at $33.5M at its later-stage round, Nov 2024. Nothing has traded since.
- ·Watch Inmedix: the Monday email on marks, rounds and moves
Inmedix funding rounds
3 roundsInmedix valuation
Inmedix was valued at $33.5 million at its later-stage round in Nov 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Inmedix raised?
Inmedix has raised $16.3 million in total; 3 of its rounds are on record, from 2021 on. The largest on record was a $720,000 seed round in Aug 2024.
Inmedix has filed 5 Form Ds with the SEC since 2021, most recently in Oct 2025 ($159,980 sold to 4 investors).
Inmedix investors
8 investors are on record for Inmedix, including Keiretsu Forum, Cairi Legacy Partners, Andrew Holman and Keiretsu Capital. The seed round in Aug 2024 drew 5 investors.
About Inmedix
Developer of a medical technology designed to assess autonomic nervous system function with clinical precision. The company offers an FDA-cleared, payer-reimbursed CloudHRV System that quantifies parasympathetic and sympathetic activity in minutes, enabling healthcare providers to make informed decisions for improved patient care.
- Sector
- Healthcare
- HQ
- Normandy Park, WA, United States
- Founded
- 2017
- Employees
- 6
- Website
- inmedix.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.